NKGen Biotech (NKGN) Competitors $0.29 +0.03 (+11.46%) As of 05/23/2025 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NKGN vs. OKYO, PRLD, STTK, IPSC, FBRX, RENB, DTIL, ARTV, ICCC, and BLUEShould you be buying NKGen Biotech stock or one of its competitors? The main competitors of NKGen Biotech include OKYO Pharma (OKYO), Prelude Therapeutics (PRLD), Shattuck Labs (STTK), Century Therapeutics (IPSC), Forte Biosciences (FBRX), Renovaro (RENB), Precision BioSciences (DTIL), Artiva Biotherapeutics (ARTV), ImmuCell (ICCC), and bluebird bio (BLUE). These companies are all part of the "pharmaceutical products" industry. NKGen Biotech vs. OKYO Pharma Prelude Therapeutics Shattuck Labs Century Therapeutics Forte Biosciences Renovaro Precision BioSciences Artiva Biotherapeutics ImmuCell bluebird bio OKYO Pharma (NASDAQ:OKYO) and NKGen Biotech (NYSE:NKGN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability. Do analysts rate OKYO or NKGN? OKYO Pharma currently has a consensus target price of $7.00, suggesting a potential upside of 278.38%. Given OKYO Pharma's stronger consensus rating and higher possible upside, equities research analysts plainly believe OKYO Pharma is more favorable than NKGen Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OKYO Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NKGen Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in OKYO or NKGN? OKYO Pharma received 11 more outperform votes than NKGen Biotech when rated by MarketBeat users. CompanyUnderperformOutperformOKYO PharmaOutperform Votes11100.00% Underperform VotesNo VotesNKGen BiotechN/AN/A Does the media prefer OKYO or NKGN? In the previous week, OKYO Pharma had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 3 mentions for OKYO Pharma and 1 mentions for NKGen Biotech. NKGen Biotech's average media sentiment score of 1.05 beat OKYO Pharma's score of -0.35 indicating that NKGen Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OKYO Pharma 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NKGen Biotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in OKYO or NKGN? 3.0% of OKYO Pharma shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are owned by institutional investors. 40.5% of OKYO Pharma shares are owned by company insiders. Comparatively, 10.4% of NKGen Biotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, OKYO or NKGN? OKYO Pharma has a beta of -0.38, meaning that its share price is 138% less volatile than the S&P 500. Comparatively, NKGen Biotech has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Is OKYO or NKGN more profitable? Company Net Margins Return on Equity Return on Assets OKYO PharmaN/A N/A N/A NKGen Biotech N/A N/A -479.36% Which has stronger earnings & valuation, OKYO or NKGN? OKYO Pharma has higher earnings, but lower revenue than NKGen Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOKYO PharmaN/AN/A-$16.83MN/AN/ANKGen Biotech$80K162.82-$82.94M-$2.45-0.12 SummaryOKYO Pharma beats NKGen Biotech on 8 of the 12 factors compared between the two stocks. Get NKGen Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NKGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NKGN vs. The Competition Export to ExcelMetricNKGen BiotechBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$13.03M$2.92B$5.33B$19.29BDividend YieldN/A1.63%5.20%3.84%P/E Ratio-0.0631.0126.7234.41Price / Sales162.82395.77395.5634.88Price / CashN/A168.6838.3217.52Price / Book-0.113.236.764.69Net Income-$82.94M-$72.35M$3.23B$1.02B7 Day Performance-17.15%1.84%0.41%-2.42%1 Month Performance136.57%1.96%9.12%6.25%1 Year Performance-84.42%-25.59%18.73%5.85% NKGen Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NKGNNKGen BiotechN/A$0.29+11.5%N/A-84.4%$13.03M$80,000.00-0.06N/APositive NewsGap UpOKYOOKYO Pharma1.6998 of 5 stars$1.54+4.1%$7.00+354.3%+24.7%$52.14MN/A0.007Gap UpPRLDPrelude Therapeutics2.7298 of 5 stars$0.88-4.4%$4.00+353.0%-78.1%$52M$7M-0.52120STTKShattuck Labs2.5603 of 5 stars$1.06-3.6%$7.50+607.5%-85.6%$51.92M$4.61M-0.71100IPSCCentury Therapeutics2.2454 of 5 stars$0.61+10.0%$4.20+588.5%-82.1%$51.78M$114.90M-0.32170News CoverageAnalyst RevisionGap DownFBRXForte Biosciences2.9084 of 5 stars$7.84-0.1%$32.50+314.5%+35,275.0%$51.61MN/A-0.485News CoverageAnalyst DowngradeRENBRenovaro1.024 of 5 stars$0.32+0.4%N/A-75.2%$50.00MN/A-0.3420News CoverageDTILPrecision BioSciences3.4753 of 5 stars$4.68-0.6%$47.00+904.3%-64.8%$49.37M$68.70M78.01200News CoverageAnalyst ForecastAnalyst RevisionARTVArtiva Biotherapeutics1.6952 of 5 stars$2.02-0.7%$19.40+862.8%N/A$49.24M$251,000.000.0081ICCCImmuCell0.1344 of 5 stars$5.38+2.1%N/A+43.0%$48.84M$26.49M-10.8170BLUEbluebird bio2.3988 of 5 stars$4.99+0.1%$44.60+794.7%-74.3%$48.81M$83.81M-0.13520 Related Companies and Tools Related Companies OKYO Pharma Alternatives Prelude Therapeutics Alternatives Shattuck Labs Alternatives Century Therapeutics Alternatives Forte Biosciences Alternatives Renovaro Alternatives Precision BioSciences Alternatives Artiva Biotherapeutics Alternatives ImmuCell Alternatives bluebird bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NKGN) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NKGN Stock Free NKGN Stock Alerts